Cargando…
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
BACKGROUND: MYC is a heterogeneously expressed transcription factor that plays a multifunctional role in many biological processes such as cell proliferation and differentiation. It is also associated with many types of cancer including the malignant lymphomas. There are two types of aggressive B-ce...
Autores principales: | Kleo, Karsten, Dimitrova, Lora, Oker, Elisabeth, Tomaszewski, Nancy, Berg, Erika, Taruttis, Franziska, Engelmann, Julia C., Schwarzfischer, Philipp, Reinders, Jörg, Spang, Rainer, Gronwald, Wolfram, Oefner, Peter J., Hummel, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451309/ https://www.ncbi.nlm.nih.gov/pubmed/30953469 http://dx.doi.org/10.1186/s12885-019-5537-0 |
Ejemplares similares
-
DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
por: Akpa, Chidimma Agatha, et al.
Publicado: (2019) -
Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011) -
Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression
por: Feist, Maren, et al.
Publicado: (2018) -
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model
por: Akpa, Chidimma Agatha, et al.
Publicado: (2020) -
Integrative genomic analysis focused on cell cycle genes for MYC-driven
aggressive mature B-cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020)